{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:24:51Z","timestamp":1792783491127,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":959,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"CH-TAC, LLC"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s13311-020-00962-y","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T13:02:54Z","timestamp":1605186174000},"page":"534-543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"title":["Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7962-0365","authenticated-orcid":false,"given":"Emmanuelle A.D.","family":"Schindler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Andrew","family":"Sewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Luddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Taylor","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Lindsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Pittman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas V.","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak C.","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1007\/s13311-020-00962-y_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","article-title":"Prevalence and burden of migraine in the United States: data from the American Migraine Study II","volume":"41","author":"Lipton","year":"2001","journal-title":"Headache."},{"issue":"4","key":"10.1007\/s13311-020-00962-y_bib2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/head.13281","article-title":"The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies","volume":"58","author":"Burch","year":"2018","journal-title":"Headache."},{"issue":"10100","key":"10.1007\/s13311-020-00962-y_bib3","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"GBD Disease and Injury Incidence and Prevalence Collaborators","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1007\/s13311-020-00962-y_bib4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/0333102414547138","article-title":"Adherence to oral migraine-preventive medications among patients with chronic migraine","volume":"35","author":"Hepp","year":"2015","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1007\/s13311-020-00962-y_bib5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1526-4610.2010.01808_1.x","article-title":"Problem child is no headache","volume":"51","author":"Sewell","year":"2011","journal-title":"Headache"},{"issue":"1","key":"10.1007\/s13311-020-00962-y_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12954-017-0186-6","article-title":"Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches","volume":"14","author":"Andersson","year":"2017","journal-title":"Harm Reduct J"},{"key":"10.1007\/s13311-020-00962-y_bib7","first-page":"116","article-title":"Prophylactic Treatment of Migraine by Means of Lysergic Acid Derivatives","volume":"6","author":"Sicuteri","year":"1963","journal-title":"Triangle"},{"issue":"5","key":"10.1007\/s13311-020-00962-y_bib8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/02791072.2015.1107664","article-title":"Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey","volume":"47","author":"Schindler","year":"2015","journal-title":"J Psychoactive Drugs"},{"issue":"12","key":"10.1007\/s13311-020-00962-y_bib9","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1212\/01.wnl.0000219761.05466.43","article-title":"Response of cluster headache to psilocybin and LSD","volume":"66","author":"Sewell","year":"2006","journal-title":"Neurology."},{"issue":"4","key":"10.1007\/s13311-020-00962-y_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/02791072.2020.1762023","article-title":"Can Psychedelics Alleviate Symptoms of Cluster Headache and Accompanying Mental Health Problems? A Case Report Involving Hawaiian Baby Woodrose","volume":"52","author":"Johnson","year":"2020","journal-title":"J Psychoactive Drugs"},{"issue":"12","key":"10.1007\/s13311-020-00962-y_bib11","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J Psychopharmacol"},{"issue":"2","key":"10.1007\/s13311-020-00962-y_bib12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology."},{"issue":"1","key":"10.1007\/s13311-020-00962-y_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0269881114555249","article-title":"LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects","volume":"29","author":"Gasser","year":"2015","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1007\/s13311-020-00962-y_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1007\/s13311-020-00962-y_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"10.1007\/s13311-020-00962-y_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J Psychopharmacol"},{"issue":"3","key":"10.1007\/s13311-020-00962-y_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1874473708666150107121331","article-title":"Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction","volume":"7","author":"Garcia-Romeu","year":"2014","journal-title":"Curr Drug Abuse Rev"},{"issue":"6","key":"10.1007\/s13311-020-00962-y_bib18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1021\/np030059u","article-title":"Concise large-scale synthesis of psilocin and psilocybin, principal hallucinogenic constituents of \u201cMagic Mushroom\u201d","volume":"66","author":"Shirota","year":"2003","journal-title":"J Nat Prod"},{"issue":"9","key":"10.1007\/s13311-020-00962-y_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The International Classification of Headache Disorders, 3rd edition (beta version)","volume":"33","author":"Headache Classification Committee of the International Headache S","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1007\/s13311-020-00962-y_bib20","doi-asserted-by":"crossref","unstructured":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2000;284(23):3043-3045.","DOI":"10.1001\/jama.284.23.3043"},{"issue":"11","key":"10.1007\/s13311-020-00962-y_bib21","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1177\/0269881110382466","article-title":"Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies","volume":"25","author":"Studerus","year":"2011","journal-title":"J Psychopharmacol"},{"issue":"2","key":"10.1007\/s13311-020-00962-y_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","article-title":"Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study","volume":"172","author":"Hasler","year":"2004","journal-title":"Psychopharmacology."},{"issue":"1-3","key":"10.1007\/s13311-020-00962-y_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2011.10.029","article-title":"Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers","volume":"123","author":"Johnson","year":"2012","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1007\/s13311-020-00962-y_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/JCP.0000000000000436","article-title":"Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study","volume":"36","author":"Sanches","year":"2016","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"10.1007\/s13311-020-00962-y_bib25","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/0269881112439253","article-title":"Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials","volume":"26","author":"Krebs","year":"2012","journal-title":"J Psychopharmacol"},{"key":"10.1007\/s13311-020-00962-y_bib26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fphar.2018.00100","article-title":"Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder","volume":"9","author":"Bogenschutz","year":"2018","journal-title":"Front Pharmacol"},{"issue":"20","key":"10.1007\/s13311-020-00962-y_bib27","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/WNL.0b013e3182377dbb","article-title":"Intravenous dihydroergotamine for inpatient management of refractory primary headaches","volume":"77","author":"Nagy","year":"2011","journal-title":"Neurology."},{"issue":"2","key":"10.1007\/s13311-020-00962-y_bib28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1526-4610.2003.03034.x","article-title":"Ergotamine and dihydroergotamine: history, pharmacology, and efficacy","volume":"43","author":"Silberstein","year":"2003","journal-title":"Headache."},{"issue":"9","key":"10.1007\/s13311-020-00962-y_bib29","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1177\/0333102410363490","article-title":"The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: an open, non-randomized case series","volume":"30","author":"Karst","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1007\/s13311-020-00962-y_bib30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fimmu.2015.00358","article-title":"Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities","volume":"6","author":"Szabo","year":"2015","journal-title":"Front Immunol"},{"issue":"5","key":"10.1007\/s13311-020-00962-y_bib31","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1152\/jn.00321.2002","article-title":"Spreading depression: imaging and blockade in the rat neocortical brain slice","volume":"88","author":"Anderson","year":"2002","journal-title":"J Neurophysiol"},{"issue":"6","key":"10.1007\/s13311-020-00962-y_bib32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4196\/kjpp.2009.13.6.425","article-title":"The Antinociceptive Effect of Sigma-1 Receptor Antagonist, BD1047, in a Capsaicin Induced Headache Model in Rats","volume":"13","author":"Kwon","year":"2009","journal-title":"Korean J Physiol Pharmacol"},{"key":"10.1007\/s13311-020-00962-y_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2018.12.004","article-title":"Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines","volume":"844","author":"Conti","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1007\/s13311-020-00962-y_bib34","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/brain\/awz134","article-title":"Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine","volume":"142","author":"Goadsby","year":"2019","journal-title":"Brain J Neurol"},{"key":"10.1007\/s13311-020-00962-y_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jocn.2017.11.011","article-title":"Changes in hormones of the hypothalamic-pituitary-gonadal axis in migraine patients","volume":"50","author":"Li","year":"2018","journal-title":"J Clin Neurosci"},{"key":"10.1007\/s13311-020-00962-y_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fphar.2018.00177","article-title":"Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics","volume":"9","author":"Schindler","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1007\/s13311-020-00962-y_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mehy.2019.02.029","article-title":"Psychedelic medicine: The biology underlying the persisting psychedelic effects","volume":"125","author":"Kuypers","year":"2019","journal-title":"Med Hypotheses"},{"issue":"6","key":"10.1007\/s13311-020-00962-y_bib38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J Psychopharmacol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00962-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-020-00962-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792301214X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792301214X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00962-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:57:22Z","timestamp":1761807442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187874792301214X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S187874792301214X"],"URL":"https:\/\/doi.org\/10.1007\/s13311-020-00962-y","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739063872.793586691","asserted-by":"object"}]},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-020-00962-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}